Concepedia
Statistics
Publications
9
Citations
422
H-Index
Active since
2007
Affiliations
Mayo Clinic(Current)
University of Washington
Mayo Clinic in Florida
Mayo Clinic in Arizona
WinnMed
Rachel M. Hurley is an author at Mayo Clinic specializing in oncology, molecular oncology, and medicine.
Publications per year
2007–2022
Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma
Ksenija Nesic, Olga Kondrashova, Rachel M. Hurley et al. · Cancer Research · 2021 · 86 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
Mariam AlHilli, Marc A. Becker, S. John Weroha et al. · Gynecologic Oncology · 2016 · 77 citations · Full text
Medicine, Oncology, Pharmacology +15
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer
Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher et al. · Gynecologic Oncology · 2019 · 74 citations · Full text
Medicine, Molecular Biology, Oncology +12
Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion
Gina L. Razidlo, Christopher Magnine, Arthur C. Sletten et al. · Cancer Research · 2015 · 54 citations · Full text
Medicine, Oncology, Pharmacology +16
Characterization of a <i>RAD51C</i> -silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
Rachel M. Hurley, Cordelia D. McGehee, Ksenija Nesic et al. · NAR Cancer · 2021 · 36 citations · Full text
1–5 of 9